One Day In July LLC Sells 122 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

One Day In July LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 805 shares of the healthcare conglomerate’s stock after selling 122 shares during the quarter. One Day In July LLC’s holdings in UnitedHealth Group were worth $422,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Financial Management Professionals Inc. lifted its stake in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares during the period. Richwood Investment Advisors LLC raised its stake in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after buying an additional 20 shares during the last quarter. Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after buying an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC raised its stake in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock valued at $1,080,000 after buying an additional 21 shares during the last quarter. Finally, Retirement Planning Group LLC raised its stake in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after buying an additional 21 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $308.69 on Friday. The stock has a 50-day simple moving average of $324.99 and a two-hundred day simple moving average of $447.32. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $280.03 billion, a PE ratio of 12.93, a P/E/G ratio of 1.48 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the firm posted $6.91 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective for the company. in a research note on Wednesday, June 11th. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. Morgan Stanley decreased their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Finally, TD Securities restated a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $415.57.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director directly owned 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the stock in a transaction dated Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.